Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease

NCT00403975 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

640

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: diquafosol tetrasodium ophthalmic solution, 2%

Sponsor

Merck Sharp & Dohme LLC